{"transactions":[{"id":4630726,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-10-05T21:11:13.000Z","date":"2026-10-01","kind":"sale","planned":false,"acquired":false,"shares":370,"price":18.96,"value":7015.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $18.96 and the range of prices were between $18.96 and $19.9599. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":56109,"source":{"system":"sec-edgar","filing":"0002048497-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000018/primarydocument.xml","form_type":"4"}},{"id":4622937,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-18T23:51:40.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":35994,"price":18.4628,"value":664550.0232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the \"10b5-1 Plan\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares."}],"balance_after":88033,"source":{"system":"sec-edgar","filing":"0002048497-26-000016","document":"form4a-09182026_110936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000016/form4a-09182026_110936.xml","form_type":"4/A","original_submission_date":"2026-09-10"}},{"id":4621187,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-17T20:15:14.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":30779,"price":20.1319,"value":619639.7501,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $20.1319 and the range of prices were between $20.00 and $20.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":56479,"source":{"system":"sec-edgar","filing":"0002048497-26-000015","document":"form4-09172026_040905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000015/form4-09172026_040905.xml","form_type":"4"}},{"id":4617984,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:15:22.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":775,"price":15.52,"value":12028.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."}],"balance_after":86382,"source":{"system":"sec-edgar","filing":"0002048497-26-000014","document":"form4-09152026_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000014/form4-09152026_040906.xml","form_type":"4"}},{"id":4614716,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-10T20:30:09.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":36870,"price":18.4628,"value":680723.436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."}],"balance_after":87157,"source":{"system":"sec-edgar","filing":"0002048497-26-000013","document":"form4-09102026_040903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000013/form4-09102026_040903.xml","form_type":"4"}},{"id":3383,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:14.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":5327,"price":19.1131,"value":101815.4837,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":124027,"source":{"system":"sec-edgar","filing":"0002048497-26-000012","document":"form4-09032026_060908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000012/form4-09032026_060908.xml","form_type":"4"}},{"id":726378,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T20:34:10.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":1258,"price":15.0083,"value":18880.4414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $15.0083 and the range of prices were between $15.00 and $15.015. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":129354,"source":{"system":"sec-edgar","filing":"0002048497-26-000009","document":"form4-06252026_080606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000009/form4-06252026_080606.xml","form_type":"4"}},{"id":747940,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T22:05:07.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":275,"price":12.31,"value":3385.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."}],"balance_after":130612,"source":{"system":"sec-edgar","filing":"0002048497-26-000008","document":"form4-06052026_060603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000008/form4-06052026_060603.xml","form_type":"4"}},{"id":751752,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:12.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":5329,"price":12.6071,"value":67183.2359,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":130887,"source":{"system":"sec-edgar","filing":"0002048497-26-000007","document":"form4-06032026_060607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000007/form4-06032026_060607.xml","form_type":"4"}},{"id":841619,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T23:55:07.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":2061,"price":30.661,"value":63192.321,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $30.6610 and the range of prices were between $30.02 and $31.0024. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":136216,"source":{"system":"sec-edgar","filing":"0002048497-26-000004","document":"form4-03162026_070303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000004/form4-03162026_070303.xml","form_type":"4"}},{"id":841618,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T23:55:07.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":856,"price":29.3359,"value":25111.5304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":138277,"source":{"system":"sec-edgar","filing":"0002048497-26-000004","document":"form4-03162026_070303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000004/form4-03162026_070303.xml","form_type":"4"}},{"id":843895,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:17.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":91520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":91520,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":91520},"source":{"system":"sec-edgar","filing":"0002048497-26-000003","document":"form4a-03132026_040307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000003/form4a-03132026_040307.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":858469,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T00:30:05.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":353,"price":11.57,"value":4084.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."}],"balance_after":139133,"source":{"system":"sec-edgar","filing":"0002048497-26-000002","document":"form4-03062026_120301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000002/form4-03062026_120301.xml","form_type":"4"}},{"id":867182,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:13.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":58749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":58749,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":58749},"source":{"system":"sec-edgar","filing":"0002048497-26-000001","document":"form4-03032026_060310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000001/form4-03032026_060310.xml","form_type":"4"}},{"id":867181,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:13.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":834,"price":12.3616,"value":10309.5744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":139486,"source":{"system":"sec-edgar","filing":"0002048497-26-000001","document":"form4-03032026_060310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000001/form4-03032026_060310.xml","form_type":"4"}},{"id":867180,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:13.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":109105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":140320,"source":{"system":"sec-edgar","filing":"0002048497-26-000001","document":"form4-03032026_060310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000001/form4-03032026_060310.xml","form_type":"4"}},{"id":1045863,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":false,"shares":11411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":21725,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":11411},"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1045862,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":false,"shares":4093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":33136,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4093},"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1045861,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":false,"shares":656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."}],"balance_after":66428,"derivative":{"exercise_price":5.1,"expiration_date":"2033-07-26","underlying":"Common Stock","underlying_shares":656},"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1045860,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":11411,"price":20.5641,"value":234656.9451,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $20.564162 and the range of prices were between $20.29 and $20.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":31215,"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1045859,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":true,"shares":11411,"price":5.1,"value":58196.1,"ownership":{"direct":true},"balance_after":42626,"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1045858,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-04","kind":"sale","planned":true,"acquired":false,"shares":6818,"price":19.9736,"value":136180.0048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.9736 and the range of prices were between $19.43 and $20.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":31215,"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1045857,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":true,"shares":4093,"price":5.1,"value":20874.3,"ownership":{"direct":true},"balance_after":38033,"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1045856,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T22:15:07.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":true,"shares":656,"price":5.1,"value":3345.6,"ownership":{"direct":true},"balance_after":33940,"source":{"system":"sec-edgar","filing":"0001415889-25-023899","document":"form4-09082025_060903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023899/form4-09082025_060903.xml","form_type":"4"}},{"id":1047917,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T22:45:07.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":848,"price":18.8632,"value":15995.9936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":33284,"source":{"system":"sec-edgar","filing":"0001415889-25-023743","document":"form4-09042025_060904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023743/form4-09042025_060904.xml","form_type":"4"}},{"id":1060263,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-21T01:30:07.000Z","date":"2025-08-19","kind":"exercise","planned":true,"acquired":false,"shares":16158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."}],"balance_after":67084,"derivative":{"exercise_price":5.1,"expiration_date":"2033-07-26","underlying":"Common Stock","underlying_shares":16158},"source":{"system":"sec-edgar","filing":"0001415889-25-022540","document":"form4-08202025_090803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925022540/form4-08202025_090803.xml","form_type":"4"}},{"id":1060262,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T01:30:07.000Z","date":"2025-08-19","kind":"sale","planned":true,"acquired":false,"shares":16158,"price":16.6095,"value":268376.301,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $16.6095 and the range of prices were between $16.26 and $17.1719. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":34132,"source":{"system":"sec-edgar","filing":"0001415889-25-022540","document":"form4-08202025_090803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925022540/form4-08202025_090803.xml","form_type":"4"}},{"id":1060261,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T01:30:07.000Z","date":"2025-08-19","kind":"exercise","planned":true,"acquired":true,"shares":16158,"price":5.1,"value":82405.8,"ownership":{"direct":true},"balance_after":50290,"source":{"system":"sec-edgar","filing":"0001415889-25-022540","document":"form4-08202025_090803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925022540/form4-08202025_090803.xml","form_type":"4"}},{"id":1122939,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:19.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":79,"price":18.691,"value":1476.589,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":34132,"source":{"system":"sec-edgar","filing":"0001415889-25-015670","document":"form4-06042025_070616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015670/form4-06042025_070616.xml","form_type":"4"}},{"id":1122938,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:19.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":551,"price":18.1489,"value":10000.0439,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":34211,"source":{"system":"sec-edgar","filing":"0001415889-25-015670","document":"form4-06042025_070616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015670/form4-06042025_070616.xml","form_type":"4"}},{"id":1122937,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:19.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":238,"price":17.028,"value":4052.664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":34762,"source":{"system":"sec-edgar","filing":"0001415889-25-015670","document":"form4-06042025_070616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015670/form4-06042025_070616.xml","form_type":"4"}},{"id":1235831,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-03T22:45:15.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025."}],"balance_after":52000,"derivative":{"exercise_price":19.91,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001415889-25-006234","document":"form4-03032025_050311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006234/form4-03032025_050311.xml","form_type":"4"}},{"id":1235830,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-03T22:45:15.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001415889-25-006234","document":"form4-03032025_050311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006234/form4-03032025_050311.xml","form_type":"4"}},{"id":1287396,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:10.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":47775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."}],"balance_after":47775,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":47775},"source":{"system":"sec-edgar","filing":"0001415889-25-002817","document":"form4-02032025_080206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002817/form4-02032025_080206.xml","form_type":"4"}},{"id":1287395,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:10.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":39424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 30, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":39424,"derivative":{"exercise_price":10.74,"expiration_date":"2034-09-29","underlying":"Common Stock","underlying_shares":39424},"source":{"system":"sec-edgar","filing":"0001415889-25-002817","document":"form4-02032025_080206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002817/form4-02032025_080206.xml","form_type":"4"}},{"id":1287394,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:10.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":17765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from January 1, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":17765,"derivative":{"exercise_price":8.51,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":17765},"source":{"system":"sec-edgar","filing":"0001415889-25-002817","document":"form4-02032025_080206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002817/form4-02032025_080206.xml","form_type":"4"}},{"id":1287393,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:10.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":37229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":37229,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":37229},"source":{"system":"sec-edgar","filing":"0001415889-25-002817","document":"form4-02032025_080206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002817/form4-02032025_080206.xml","form_type":"4"}},{"id":1287392,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:10.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":83242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":83242,"derivative":{"exercise_price":5.1,"expiration_date":"2033-07-26","underlying":"Common Stock","underlying_shares":83242},"source":{"system":"sec-edgar","filing":"0001415889-25-002817","document":"form4-02032025_080206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002817/form4-02032025_080206.xml","form_type":"4"}},{"id":1289522,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T21:31:56.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":47775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":47775,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Class B Common Stock","underlying_shares":47775},"source":{"system":"sec-edgar","filing":"0001415889-25-002480","document":"form4-01312025_090153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002480/form4-01312025_090153.xml","form_type":"4"}}]}